• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺导管腺癌中异质性核核糖核蛋白M表达降低导致的葡萄糖代谢改变

Alterations in Glucose Metabolism Due to Decreased Expression of Heterogeneous Nuclear Ribonucleoprotein M in Pancreatic Ductal Adenocarcinoma.

作者信息

Takino Jun-Ichi, Sato Takuma, Hiraishi Isamu, Nagamine Kentaro, Hori Takamitsu

机构信息

Faculty of Pharmaceutical Sciences, Hiroshima International University, 5-1-1 Hirokoshingai, Kure, Hiroshima 737-0112, Japan.

Faculty of Health Sciences, Hiroshima International University, 5-1-1 Hirokoshingai, Kure, Hiroshima 737-0112, Japan.

出版信息

Biology (Basel). 2021 Jan 14;10(1):57. doi: 10.3390/biology10010057.

DOI:10.3390/biology10010057
PMID:33466816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7830884/
Abstract

The prognosis of pancreatic cancer is considerably worse than that of other cancers, as early detection of pancreatic cancer is difficult and due to its hypovascular environment, which involves low blood flow and a low supply of oxygen and nutrients. Moreover, pancreatic cancer demonstrates a mechanism that allows it to survive in a hypovascular environment. However, the detailed mechanism remains elusive. Recently, it has been reported that heterogeneous ribonuclear protein M (HNRNPM) is a splicing factor associated with malignant tumors. Thus, in this study, we investigated the expression and effects of HNRNPM in pancreatic ductal adenocarcinoma (PDA). We observed that HNRNPM expression, which is highly expressed in pancreatic tissues, was reduced in PDA tissues. Additionally, knockdown of HNRNPM under low-glucose conditions that mimic a hypovascular environment was shown to alter glucose metabolism and prolong cell survival by suppressing glucose consumption. These results suggest that the decreased expression of HNRNPM in PDA may be involved in its adaptation to a hypovascular environment.

摘要

胰腺癌的预后比其他癌症要差得多,这是因为胰腺癌很难早期发现,且其血管生成不足,即血流量低,氧气和营养物质供应少。此外,胰腺癌表现出一种使其能在血管生成不足的环境中存活的机制。然而,具体机制仍不清楚。最近有报道称,异质性核糖核蛋白M(HNRNPM)是一种与恶性肿瘤相关的剪接因子。因此,在本研究中,我们调查了HNRNPM在胰腺导管腺癌(PDA)中的表达及作用。我们观察到,HNRNPM在胰腺组织中高表达,而在PDA组织中表达降低。此外,在模拟血管生成不足环境的低糖条件下敲低HNRNPM,结果显示可通过抑制葡萄糖消耗来改变葡萄糖代谢并延长细胞存活时间。这些结果表明,PDA中HNRNPM表达降低可能与其适应血管生成不足的环境有关。

相似文献

1
Alterations in Glucose Metabolism Due to Decreased Expression of Heterogeneous Nuclear Ribonucleoprotein M in Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌中异质性核核糖核蛋白M表达降低导致的葡萄糖代谢改变
Biology (Basel). 2021 Jan 14;10(1):57. doi: 10.3390/biology10010057.
2
hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.hnRNPM,一种潜在的 YY1 介导物,可促进前列腺癌细胞的上皮-间充质转化。
Prostate. 2019 Aug;79(11):1199-1210. doi: 10.1002/pros.23790.
3
Heterogeneous nuclear ribonucleoprotein M promotes the progression of breast cancer by regulating the axin/β-catenin signaling pathway.异质核核糖核蛋白 M 通过调节轴突/β-连环蛋白信号通路促进乳腺癌的进展。
Biomed Pharmacother. 2018 Sep;105:848-855. doi: 10.1016/j.biopha.2018.05.014. Epub 2018 Jun 18.
4
HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness.HNRNPM 控制 circRNA 的生物发生和剪接保真度,以维持癌细胞的适应性。
Elife. 2021 Jun 2;10:e59654. doi: 10.7554/eLife.59654.
5
Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.在 EMT 过程中,hnRNPM 和 ESRP1 对可变剪接的共同调控。
RNA. 2018 Oct;24(10):1326-1338. doi: 10.1261/rna.066712.118. Epub 2018 Jul 24.
6
HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases.HnRNPM和CD44s的表达影响肿瘤侵袭性,并预测伴有腋窝淋巴结转移的乳腺癌预后不良。
Genes Chromosomes Cancer. 2017 Aug;56(8):598-607. doi: 10.1002/gcc.22463. Epub 2017 May 4.
7
hnRNPM induces translation switch under hypoxia to promote colon cancer development.hnRNPM 在低氧条件下诱导翻译开关,促进结肠癌的发展。
EBioMedicine. 2019 Mar;41:299-309. doi: 10.1016/j.ebiom.2019.02.059. Epub 2019 Mar 7.
8
hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells.异质性核糖核蛋白M(hnRNPM)可引导一个可变剪接程序,以响应尤因肉瘤细胞中PI3K/AKT/mTOR信号通路的抑制。
Nucleic Acids Res. 2017 Dec 1;45(21):12270-12284. doi: 10.1093/nar/gkx831.
9
The heterogeneous nuclear ribonucleoprotein hnRNPM inhibits RNA virus-triggered innate immunity by antagonizing RNA sensing of RIG-I-like receptors.异质核核糖核蛋白 hnRNPM 通过拮抗 RIG-I 样受体的 RNA 感应来抑制 RNA 病毒触发的先天免疫。
PLoS Pathog. 2019 Aug 21;15(8):e1007983. doi: 10.1371/journal.ppat.1007983. eCollection 2019 Aug.
10
Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.癌症相关的 MORC2 突变 M276I 通过调控 hnRNPM 介导的 CD44 剪接开关促进三阴性乳腺癌的侵袭和转移。
Cancer Res. 2018 Oct 15;78(20):5780-5792. doi: 10.1158/0008-5472.CAN-17-1394. Epub 2018 Aug 9.

引用本文的文献

1
Unveiling the Potential Role of Hesperetin and Emodin as a Combination Therapy to Inhibit the Pancreatic Cancer Progression against the C-Met Gene.揭示橙皮素和大黄素联合治疗对抑制胰腺癌进展及针对C-Met基因的潜在作用。
Protein Pept Lett. 2025;32(4):280-298. doi: 10.2174/0109298665363165250225100109.
2
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential.胰腺导管腺癌中的剪接改变:具有转化潜力的新分子图谱。
J Exp Clin Cancer Res. 2023 Oct 26;42(1):282. doi: 10.1186/s13046-023-02858-z.

本文引用的文献

1
New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma.转移性胰腺导管腺癌的新治疗策略。
Drugs. 2020 May;80(7):647-669. doi: 10.1007/s40265-020-01304-0.
2
Poison-Exon Inclusion in DHX9 Reduces Its Expression and Sensitizes Ewing Sarcoma Cells to Chemotherapeutic Treatment.DHX9 中的外显子包含物降低了其表达水平,并使尤文肉瘤细胞对化疗药物更敏感。
Cells. 2020 Jan 31;9(2):328. doi: 10.3390/cells9020328.
3
hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
hnRNPM,一种潜在的 YY1 介导物,可促进前列腺癌细胞的上皮-间充质转化。
Prostate. 2019 Aug;79(11):1199-1210. doi: 10.1002/pros.23790.
4
hnRNPM induces translation switch under hypoxia to promote colon cancer development.hnRNPM 在低氧条件下诱导翻译开关,促进结肠癌的发展。
EBioMedicine. 2019 Mar;41:299-309. doi: 10.1016/j.ebiom.2019.02.059. Epub 2019 Mar 7.
5
Metabolic Dependencies in Pancreatic Cancer.胰腺癌中的代谢依赖性
Front Oncol. 2018 Dec 12;8:617. doi: 10.3389/fonc.2018.00617. eCollection 2018.
6
Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.癌症相关的 MORC2 突变 M276I 通过调控 hnRNPM 介导的 CD44 剪接开关促进三阴性乳腺癌的侵袭和转移。
Cancer Res. 2018 Oct 15;78(20):5780-5792. doi: 10.1158/0008-5472.CAN-17-1394. Epub 2018 Aug 9.
7
Heterogeneous nuclear ribonucleoprotein M promotes the progression of breast cancer by regulating the axin/β-catenin signaling pathway.异质核核糖核蛋白 M 通过调节轴突/β-连环蛋白信号通路促进乳腺癌的进展。
Biomed Pharmacother. 2018 Sep;105:848-855. doi: 10.1016/j.biopha.2018.05.014. Epub 2018 Jun 18.
8
hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells.异质性核糖核蛋白M(hnRNPM)可引导一个可变剪接程序,以响应尤因肉瘤细胞中PI3K/AKT/mTOR信号通路的抑制。
Nucleic Acids Res. 2017 Dec 1;45(21):12270-12284. doi: 10.1093/nar/gkx831.
9
Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells.HuR对异柠檬酸脱氢酶1(IDH1)的转录后上调在胰腺癌细胞中建立了强大的生存表型。
Cancer Res. 2017 Aug 15;77(16):4460-4471. doi: 10.1158/0008-5472.CAN-17-0015. Epub 2017 Jun 26.
10
The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer.HRNPM和SLC1A5在上皮性卵巢癌发病机制及预后中的临床与预后相关性
PLoS One. 2017 Jun 13;12(6):e0179363. doi: 10.1371/journal.pone.0179363. eCollection 2017.